で公開中です! 詳しく見る
TRAXのアイコン

First Tracks Biotherapeutics

名前 保有額 取引額 株数
増減
保有比率の
変化
EcoR1 Capital
1
EcoR1 Capital
California
$6387万 +$5935万 +3,174,519 新規
TCG Crossover Management
2
TCG Crossover Management
California
$5825万 +$5413万 +2,895,304 新規
Fidelity Investments
3
Fidelity Investments
Massachusetts
$4133万 +$3840万 +2,054,127 新規
Affinity Asset Advisors
4
Affinity Asset Advisors
New York
$4088万 +$3799万 +2,032,012 新規
BlackRock
5
BlackRock
New York
$3951万 +$3671万 +1,963,541 新規
Trails Edge Capital Partners
6
Trails Edge Capital Partners
Georgia
$3046万 +$2830万 +1,514,000 新規
State Street
7
State Street
Massachusetts
$3044万 +$2828万 +1,512,896 新規
Vanguard Capital Management
8
Vanguard Capital Management
Pennsylvania
$2921万 +$2714万 +1,451,909 新規
Jupiter Topco
9
Jupiter Topco
New York
$2196万 +$2041万 +1,091,464 新規
Vestal Point Capital
10
Vestal Point Capital
New York
$2038万 +$1894万 +1,013,000 新規
Woodline Partners
11
Woodline Partners
California
$1845万 +$1715万 +917,176 新規
S
12
Sanofi
France
$1654万 +$1537万 +821,917 新規
Morgan Stanley
13
Morgan Stanley
New York
$1572万 +$1461万 +781,534 新規
6CM
14
683 Capital Management
New York
$1509万 +$1402万 +750,000 新規
Adage Capital Partners
15
Adage Capital Partners
Massachusetts
$1467万 +$1363万 +729,000 新規
Balyasny Asset Management
16
Balyasny Asset Management
Illinois
$1438万 +$1337万 +714,948 新規
Geode Capital Management
17
Geode Capital Management
Massachusetts
$1413万 +$1313万 +702,087 新規
Bank of America
18
Bank of America
North Carolina
$1304万 +$1211万 +647,962 新規
SC
19
Stempoint Capital
New York
$1253万 +$1164万 +622,723 新規
Palo Alto Investors
20
Palo Alto Investors
California
$1214万 +$1128万 +603,489 新規
Sofinnova Investments
21
Sofinnova Investments
California
$1137万 +$1057万 +565,199 新規
Vanguard Portfolio Management
22
Vanguard Portfolio Management
Pennsylvania
$1101万 +$1023万 +546,992 新規
Goldman Sachs
23
Goldman Sachs
New York
$980万 +$911万 +487,213 新規
Point72 Asset Management
24
Point72 Asset Management
Connecticut
$822万 +$763万 +408,330 新規
UBS Group
25
UBS Group
Switzerland
$626万 +$581万 +310,886 新規